Biotechnology Soon To Be Acquired Cerevel Therapeutics Reveals High Level Data From Late-Stage Parkinson’s Disease Study – Cerevel Therapeutics Hldg (NASDAQ:CERE) Read more
Biotechnology Palatin Technologies Eyes Growing $6B Dry Eye Disease Market With Late-Stage Study Data Why Is Palatin Technologies Stock Soaring On Monday? – Palatin Techs (AMEX:PTN) Read more
Biotechnology After Failed Prostate Cancer Study Merck’s Keytruda Combination Therapy Flunks In Late-Stage Lung Cancer Study – Merck & Co (NYSE:MRK) Read more
Biotechnology First Wave BioPharma Announces Completion of Business Combination with ImmunogenX, Adding Phase 3-Ready Latiglutenase to its Late-Stage GI-Focused Clinical Pipeline – First Wave BioPharma (NASDAQ:FWBI) Read more
Biotechnology Acelyrin’s Lead Drug Candidate Hits Primary Goal In Late-Stage Psoriatic Arthritis Study – Acelyrin (NASDAQ:SLRN) Read more
Biotechnology GSK's Withdrawn Multiple Myeloma Drug Shows Encouraging Combination Therapy Data In Second Late-Stage Study Read more
Stockmarkets Vertex non-opioid painkiller meets main goal in late-stage trials Reuters via biedexmarkets.com Read more